Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled study of MDMA-assisted psychotherapy for PTSD
MOH_2020-09-16_008682Phase 3Completed
- Sponsor
- Lykos Therapeutics
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in post-traumatic stress disorder (PTSD) comparing Psychotherapy + midomafetamine with Psychotherapy + placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Apr 2020; status: completed.
02
Drugs
midomafetamine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on MOH_2020-09-16_008682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-09-16_008682.